Sutro Biopharma (STRO) PT Raised to $37 at Truist Securities

January 28, 2021 7:05 AM EST
Get Alerts STRO Hot Sheet
Price: $19.68 -1.5%

Rating Summary:
    11 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 3 | New: 9
Trade Now! 
Join SI Premium – FREE
Truist Securities analyst Asthika Goonewardene raised the price target on Sutro Biopharma (NASDAQ: STRO) to $37.00 (from $24.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change